Nihat Sapan

Clinical features associated with Pseudomonas aeruginosa colonization in children under 2 years of age: a retrospective study of Cystic Fibrosis Registry

Ece Ocak, Güzin Cinel, Gökçen Dilşa Tuğcu, Sanem Eryılmaz Polat et autres

BACKGROUND: Respiratory colonization with Pseudomonas aeruginosa is associated with increased morbidity and mortality in cystic fibrosis (CF) patients. This study aims to assess the clinical characteristics and associated factors of CF infants under two years of age with P. aeruginosa colonization in …

tr, fi (code pays fourni par la source)

Evaluation of Asthma Control in Patients with Asthma and Factors Affecting Asthma Control in Childhood Asthma

Nihat Sapan, Sabahattin Karakaya, Şükrü Çekiç, Yakup Canıtez et autres

Objective: Asthma is the most common chronic disease of childhood. The goal of asthma treatment is to achieve complete control of the damage. This study aimed to investigate the control status of children diagnosed with asthma aged 4-18 years, using asthma control …

tr (code pays fourni par la source)

Genotype-phenotype correlation of CFTR variants in cystic fibrosis patients

Yakup Canitez, Şebnem Özemri Sağ, Nurdeniz Nalbant, Adem Alemdar et autres

tr (code pays fourni par la source)

Phenotypes of Food Allergies in Patients with Atopic Dermatitis Aged Under 24 Months: A Multicenter Study

Müjde Tuba Çöğürlü, Metin Aydoğan, Özlem Cavkaytar, Pınar Uysal et autres

Background: Atopic dermatitis (AD) and food allergy (FA) are common allergic diseases in early childhood. AD may be concomitant with FA, particularly in young children. Although studies report the prevalence of FA in children with AD, there is insufficient data regarding different …

tr (code pays fourni par la source)

Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast Treatment

Seda Tunca, Özge Yılmaz, Merve Öcalan, Mustafa Arga et autres

BACKGROUND: Montelukast is a leukotriene receptor antagonist commonly used in allergic diseases. In this study, we investigated the frequency, severity and risk factors for neuropsychiatric side effects and sleep disorders associated with montelukast in children. METHOD: Children aged 6 months to 17 …

tr (code pays fourni par la source)

The Efficacy of Different Dosing Regimens of Omalizumab in Children and Adolescents with Chronic Spontaneous Urticaria Based on Real-Life Data

Yakup Canıtez, Deniz Özçeker, Pınar Uysal, Öner Özdemır et autres

INTRODUCTION: Limited data are available regarding the effectiveness of different omalizumab-dosing strategies in childhood chronic spontaneous urticaria (CSU). This study aimed to investigate the efficacy of omalizumab initiated at different doses in children and adolescents with CSU based on real-life data. METHODS: …

tr (code pays fourni par la source)

A Clinical Profile of Ige-Mediated Food Allergies in Children: Experience from Bursa Uludag University

Şeyma Şanlı, Gözde Özkan, Şükrü Çekiç, Yakup Canıtez et autres

A retrospective cohort study of children diagnosed with Cystic Fibrosis after implementation of a newborn screening program in Turkey

Handan Kekeç, Tuğba Şişmanlar Eyüboğlu, Ayşe Tana Aslan, Zeynep İlkşen Hocoğlu et autres

tr, us (code pays fourni par la source)

Climate Change and Its Effects on Childhood Allergic Diseases

Gözde Özkan, Şükrü Çekiç, Nihat Sapan

Factors associated with pulmonary function decline of patients in the cystic fibrosis registry of Turkey: A retrospective cohort study

Nagehan Emiralioğlu, Banu Cakir, Ahmet Sertçelik, Ebru Elmas Yalcin et autres

BACKGROUND: The decline in pulmonary function is a predictor of disease progression in patients with cystic fibrosis (CF). This study aimed to determine the decline rate of percent predicted forced expiratory volume in 1 s (ppFEV1) based on the data of the …

tr (code pays fourni par la source)

P005 Seven-year follow-up of patients with cystic fibrosis after newborn screening program

Handan Kekeç, Tuğba Şişmanlar Eyüboğlu, Ayşe Tana Aslan, Zeynep İlkşen Hocoğlu et autres

tr, us (code pays fourni par la source)

Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?

Salih Uytun, Güzin Cinel, Sanem Eryılmaz Polat, Satı Özkan Tabakçı et autres

BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive disorder caused by CF transmembrane conductance regulator (CFTR) genetic variants. CFTR modulators improve pulmonary function and reduce respiratory infections in CF. This study investigated the clinical and laboratory follow-up parameters over 1 year in …

tr (code pays fourni par la source)